Medical Membrane Devices: Markets and Technologies

Sep 2015| MST043F| BCC Publishing

Report Highlights

Global revenue for medical membrane devices was valued at $25.2 billion in 2013 and $25.6 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 2.3% from 2015 through 2020; reach $26.3 billion by 2015 and $29.4 billion by 2020.

Report Includes

  • An overview of the global markets and technologies for medical membrane devices.
  • Analyses of global market trends, with data from 2013 and 2014, estimates for 2015, and projections of CAGRs through 2020.
  • Analysis of the relevant technical and economic drivers for the medical membrane device market by technology type.
  • Information on the impact of device applications and trends, pricing considerations, research and development (R&D), and environmental influences.
  • Evaluation of the industry structure.
  • Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
  • A frame for membrane components of each sector in context with the market dynamics of the overall technology.
  • Profiles of major companies in the field along with a competitive technology analysis.


The scope of this report encompasses key market analysis, market drivers, market constraints and also competitive developments and trends in the market. BCC Research analyzes each market and its applications, regulatory environment, technology, market projections and market shares. This report involves the medical membrane devices used in the medical device industry. This report mainly deals with the medical membrane devices market covering the total market, which includes hemodialyzers, membrane oxygenators, intravenous infusion (IV) infusion filters, blood microfilters/apheresis system and membrane diagnostic devices. The report also covers the use of medical membrane devices for cardiopulmonary treatments, renal diseases, parenteral administration and home care diagnosis. It also covers details about healthcare spending and the U.S. healthcare system.

Excluded from this report are membranes employed in other facets of medicine. These applications and devices include hollow fiber bioreactors employed in the production of monoclonal antibodies, recombinant proteins and drugs, nonseparating membranes used in drug-delivery systems, tissue scaffolding and synthetic skin. In addition, experimental artificial organs (liver, pancreas, implanted lung); apheresis filtration for stem cell recovery, virus filters and other cross-flow filters used in the production of pharmaceuticals; and blotting membranes (excluding their application in diagnostics) will not be considered in this report.

Complete geographical analysis of market is also provided. The emerging market for medical membrane devices includes India, China, Japan, Korea, Taiwan, Canada, Africa, Australia, New Zealand, etc. Profiles of key market players are also included in this report.

Technological issues discussed include latest trends, pipeline products and developments. The key market players include Baxter International, Fresenius Medical Care, NxStage Medical, B. Braun Medical, Toray Industries, Terumo Corp., Medtronic, Sorin Group and diagnostic companies like Abbott, Alere, Quidel, Response Biomedical, Roche, Siemens and several others.

Frequently Asked Questions (FAQs)

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter NamePagesPrice Member Price
Full Report: Medical Membrane Devices: Markets and Technologies142 $2,750 Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY2$250Free
Chapter- 3: OVERVIEW17$329Free
Chapter- 4: REGULATORY ASPECTS18$349Free
Chapter- 5: NEW DEVELOPMENTS9$174Free
Chapter- 6: GLOBAL MARKET ANALYSIS26$504Free
Chapter- 7: INDUSTRY STRUCTURE12$232Free
Chapter- 8: PATENT ANALYSIS11$213Free
Chapter- 10: COMPANY PROFILES25$484Free
Chapter- 11: ABBREVIATIONS2$39Free
Published - Jan-2012| Analyst - Susan Hanft| Code - MST043E

Report Highlights

The U.S. medical membrane device market was valued at $2.1 billion in 2010 and is expected to be nearly $2.2 billion by the end of 2011. This market is forecast to grow to $2.9 billion by 2016, a compound annual growth rate (CAGR) of 5%.


Published - Jul-2009| Analyst - Susan Hanft| Code - MST043D

Report Highlights

  • The medical membrane device market, which includes dialyzers, blood oxygenators, IV filters and blood/apheresis filters, is valued at nearly $2 billion in 2009 and is expected to increase at a compound annual growth rate (CAGR) of 4.6% through 2014
  • Sales of dialyzers and blood oxygenators and IV filters are primarily market-driven, while sales of blood/apheresis filters and diagnostic devices are principally technology-driven
  • Sales of diagnostic devices continue to skyrocket. Applauded by managed care, a growing number of point-of-care (POC) and home tests are available for a host of new and existing applications.
Published - May-2007| Analyst - Susan Hanft| Code - MST043C

Report Highlights

  • The medical membrane device market, including dialyzers, blood oxygenators, IV filters and blood/apheresis filters, is valued at nearly $1.8 billion in 2007 and is increasing at a compound annual growth rate (CAGR) of 5.3% to reach $ 2.3 billion in 2012.
  • The combined worth of market-driven devices is about $623 million, rising at a compound annual growth rate of 3.6%. More than 235,000 U.S. kidney patients require dialysis on an ongoing basis to maintain renal function. Growth in the hemodialyzer market is driven by an increasing patient population, the phaseout of reusable dialyzers and the discovery that nonmembrane home dialysis may be applicable to a broader target audience
  • Technology driven products, such as blood/apheresis microfilters and diagnostic devices, have a combined value of $1.1 billion, with a 6.2% CAGR. Sales of these products for the most part, are spurred by improvements in design and materials, and by new applications.
Published - Jan-2002| Analyst - Susan Hanft| Code - MST043B

Report Highlights

  • The U.S. medical membrane device market is valued at $1.7 billion in 2001.
  • Increasing at an average annual growth rate (AAGR) of 7.1%, this market is expected to reach nearly $2.5 billion in 2006.
  • Sales of dialyzers and blood oxygenators, and increasingly leukofilters, are primarily market driven and are valued at $883 million in 2001 and growing at an AAGR 8.1%.
  • Sales of IV filters, blood/apheresis filters and diagnostic devices are principally technology driven and have a combined value of $859 million, with a 5.9% AAGR.
  • Sales of diagnostic devices have skyrocketed, driven by managed care, point-of-care and home tests for a host of applications.

Medical Membrane Devices: Markets and Technologies

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries